Brief: Amphastar Pharmaceuticals Inc On March 8 Co And Nanjing Hanxin Pharmaceutical Technology Entered Amendment To Contract Research Agreement
10/03/2023 21:36
March 10 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR PHARMACEUTICALS INC: ON MARCH 8 CO AND NANJING
HANXIN
PHARMACEUTICAL TECHNOLOGY ENTERED AMENDMENT TO CONTRACT RESEARCH
AGREEMENT
* AMPHASTAR PHARMACEUTICALS - UNDER AMENDMENT, HANXIN TO
PERFORM
SCALE-UP MANUFACTURING PROCESS DEVELOPMENT USING RECOMBINANT
HUMAN INSULIN RCBS FOR CO
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray